News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
182 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (21900)
Month
January (2433)
February (2866)
March (3029)
April (3115)
May (3356)
June (2725)
July (2286)
August (2090)
Day
1 (117)
2 (174)
3 (44)
5 (18)
6 (63)
7 (148)
8 (162)
9 (80)
10 (92)
12 (11)
13 (86)
14 (145)
15 (167)
16 (131)
17 (117)
19 (12)
20 (202)
21 (171)
22 (152)
23 (182)
24 (89)
26 (24)
27 (111)
28 (193)
29 (219)
30 (205)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
Day
1
2
3
5
6
7
8
9
10
12
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
Manufacturing
AbbVie commits $1.4B to NC plant in its largest-ever single campus investment
The Durham plant will manufacture immunology, neuroscience and oncology drugs once AbbVie finishes construction in 2028.
April 23, 2026
·
2 min read
·
Nick Paul Taylor
Neuroscience
AAN 2026: J&J, Kyverna, Capricor and Praxis showcase practice-changing data
This year’s American Academy of Neurology meeting included a presentation that could one day set a new treatment standard for myasthenia gravis.
April 23, 2026
·
4 min read
·
Tristan Manalac
Complete response letters
Unnamed pharma files citizen petition targeting FDA’s trove of rejection letters
The FDA in July 2025 made publicly available over 200 complete response letters—an initiative that the investment community sees as “unanimously positive,” analysts told
BioSpace
.
April 23, 2026
·
2 min read
·
Tristan Manalac
Obesity
Roche insists amylin obesity drug still valuable for patients who ‘don’t want side effects’
Roche and Zealand Pharma announced last month that their amylin analog petrelintide elicited a 9% placebo-controlled weight reduction at 42 weeks—falling far below analyst and investor expectations.
April 23, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Aurora Spine Corporation Schedules Release of Fourth Quarter and Fiscal 2025 Financial Results
April 23, 2026
·
3 min read
Press Releases
Ocugen to Present at April 2026 Investor and Industry Conferences
April 23, 2026
·
3 min read
Press Releases
Kymera Therapeutics to Report First Quarter 2026 Financial Results on April 30, 2026
April 23, 2026
·
1 min read
Press Releases
Conavi Medical Awarded 2026 TAG Innovation Award
April 23, 2026
·
5 min read
Press Releases
Genenta signs Definitive Agreements with Sophia High Tech
April 23, 2026
·
7 min read
Press Releases
Antag Therapeutics to present data on AT7687, its first-in-class GIPR antagonist peptide at the American Diabetes Association’s 2026 Scientific Sessions
April 23, 2026
·
2 min read
Previous
12 of 19
Next